The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on Saturday.
The information was shared by Taranjit Singh Sandhu, Ambassador of India to the United States on Twitter.
"Third consignment from @GileadSciences of 25000 doses of Remdesivir from United States reach India! 180000 doses have reached so far. More to follow. Thank you @GileadSciences!" tweeted Mr Sandhu.
Gilead Sciences, the developer of antiviral drug Remdesivir had sent more than 1.8 lakh vials to India.
Last month, Gilead spokesperson had told Sputnik that it will provide all its licensing partners in India with the technical support for the addition of new manufacturing facilities but will not send any more specialists there.
Several countries around the globe including the UK, Russia, and the US have extended support to India as it continues to struggle with the increase in its health infrastructure needs.
India reported 4,01,078 new COVID-19 cases, and 4,187 deaths in the last 24 hours, according to the Union Health Ministry.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
US Lawmakers Back Covid Chinese Lab Leak Theory After Two-Year Probe New XEC Covid Variant Spreads To 27 Countries, Here's What We Know So Far Study Shows How Long Covid Is Debilitating Children's Health Is Safe Car Enough? Volvo Crash That Killed CEO, Family Sparks Big Question "Nothing Short Of Nightmare": Woman Misses Life Event, Slams Air India Snack Food Epigamia Founder Rohan Mirchandani Dies Of Cardiac Arrest At 41 India, Kuwait Sign 4 MoUs To Strengthen Cultural, Defence Cooperation Couple Caught Smuggling Luxury Watches Worth Rs 13 Crore In Gujarat "Saw Bouncers Behaving Recklessly": Cops On 'Pushpa 2' Premiere Stampede Track Latest News Live on NDTV.com and get news updates from India and around the world.